New search | Conferencedetail
Print view

International Cannabinoid Derived Pharmaceuticals Summit

evvnt Platform / evvnt
Conference themes
With 17+ hours of content, we will be tackling the key issues from the benchside to commercialization. By considering a range of therapeutic areas, the conference is designed exclusively for the Cannabinoid drug developer. Our speakers will discuss complex Cannabinoid pharmacology, formulations, clinical trials, patient education and commercial challenges.
Professional congress organizer (PCO)
Hanson Wade
Speakers: Chris Bunka, Chairman of the Board and Chief Executive Officer, Lexaria Biosciences, Tamas Biro, Professor, Research Center for Molecular Medicine Departments of Immunology and Physiology, University of Debrecen, and others

Enquiries and Registration:
Ms. Kaltrina Kastrati
Pharmacology and Toxicology
Congress fees
Conference Only: GBP 1999.0, Conference + 2 Workshops: GBP 2897.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.European Public Health Association (EUPHA)Center of ExcellenceFFG - 7. EU-RahmenprogrammCharité International AcademyÄrztekammer für WienAMREF - African Medical and Research Foundation


Give us your professional opinion

Start survey

Start survey